Abstract
Background To explore whether the use of cigarettes affects the prevalence of obstructive sleep apnea (OSA) in adults.
Methods A questionnaire-based cross-sectional study was conducted among 233 participants. The questionnaire link was published on November 13, 2023 on social media sites and the Internet.The adults were divided into four groups: noncurrent smokers, current electronic cigarettes (e-cigarette) users only, current conventional cigarettes (c-cigarette) users only, and dual users. OSA was assessed by three main signs and symptoms from the questionnaire. Multivariable logistic regression after adjusting for covariates was conducted to investigate the association of OSA with different smoking patterns.
The sample size was calculated as 233 to a population of 12,900000 with a margin error of 5% and a confidence interval of 95% using a sample size calculator.
Results Among the 233 participants, the prevalence of OSA was higher among smokers compared to non-smokers.
the distribution of the prevalence of OSA among continuous smokers (16%), intermittent smokers (36%), and passive smokers (24%).
As for those undiagnosed with OSA, the percentage of smokers was 40%, passive smoking was 12.9%, and intermittent smokers were 17.1%.
As for OSA patients who were non-smokers, they constituted 24%.
By calculating the P-VALUE, which amounted to < 0.001, which indicates a relationship between smoking and sleep apnea.
Conclusion Our study found that 68% of sleep apnea patients were smokers, with 24% passive smoking, 36% smoking regular cigarettes, 24% smoking hookah, and 8% smoking electronic cigarettes, which confirmed that sleep apnea is more related to smoking regular cigarettes than Electronic cigarettes
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Syrian Private University gave approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
all data are available at request
